Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,590.00p
   
  • Change Today:
      90.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 2,350.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 12,280
  • Market Cap: £135.32m

Bioventix Overview

Bioventix was founded in 2003 as a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics. However, the antibody technology laboratory and some of the staff have been based at the same location in Farnham, Surrey, UK since the early 1990s.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 6.0% 0.0%
Div Cover 1.0 1.0
Op Mrgn 77.8% 74.8%
ROCE 75.6%  
Latest F'cast
P/E 16.7 16.5
PEG n/a n/a
Pr/Revenue 9.9 9.7
Pr/Book 11.3  
Latest F'cast
Revenue 6.2% -0.8%
PBT 4.6% -4.7%
EPS -3.4% -2.3%
DPS 2.0% -0.0%

Bioventix Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-20 10.31 8.23 139.41p 29.8 1.4 +22% 88.00p 2.1%
30-Jun-21 10.93 8.12 129.22p 30.7 n/a -7% 105.00p 2.6%
30-Jun-22 11.72 9.28 147.32p 23.4 1.7 +14% 126.00p 3.7%
30-Jun-23 12.82 10.13 160.63p 24.0 2.7 +9% 152.00p 3.9%
30-Jun-24 13.61 10.60 155.12p 28.4 n/a -3% 155.00p 3.5%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Bioventix Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-25 13.50 10.10 151.50p 17.1 n/a -2% 155.00p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Bioventix Company Announcements

Exercise of Options and Issue of Equity 11-Apr-2025 07:00 RNS
Interim Results 31-Mar-2025 07:00 RNS
Director Dealing 24-Dec-2024 09:14 RNS

Latest Bioventix Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,590.00p
Change Today 90.00p
% Change 3.60 %
52 Week High 4,500.00
52 Week Low 2,350.00
Volume 12,280
Shares Issued 5.22m
Market Cap £135.32m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
9.22% below the market average9.22% below the market average9.22% below the market average9.22% below the market average9.22% below the market average
61.70% above the sector average61.70% above the sector average61.70% above the sector average61.70% above the sector average61.70% above the sector average
Price Trend
63.51% below the market average63.51% below the market average63.51% below the market average63.51% below the market average63.51% below the market average
29.17% below the sector average29.17% below the sector average29.17% below the sector average29.17% below the sector average29.17% below the sector average
Income
46.25% above the market average46.25% above the market average46.25% above the market average46.25% above the market average46.25% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
22.73% below the market average22.73% below the market average22.73% below the market average22.73% below the market average22.73% below the market average
6.25% below the sector average6.25% below the sector average6.25% below the sector average6.25% below the sector average6.25% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 25-Apr-2025

Time Volume / Share Price
09:23 5,500 @ 2,475.00p
16:35 253 @ 2,590.00p
16:35 1 @ 2,590.00p
16:35 252 @ 2,590.00p
16:28 30 @ 2,578.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page